Loading...

Brilliant Violet 510™ anti-mouse CD45 Antibody Brilliant Violet 510™ anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30F11_BV510_CD45_Antibody_FC_083112
C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
  • 30F11_BV510_CD45_Antibody_FC_083112
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
Compare all formats See Brilliant Violet 510™ spectral data
Cat # Size Price Quantity Check Availability Save
103137 125 µL NOK1502
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103138 50 µg NOK1997
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. For immunofluorescent staining using the µl size, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  2. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  3. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  4. Yang Z, et al. 2022. Cancer Discov. 12:1942. PubMed
  5. Garnier L, et al. 2022. Sci Adv. 8:eabl5162. PubMed
  6. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  7. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  8. Caslin HL, et al. 2023. Front Immunol. 13:984859. PubMed
  9. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  10. Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed
  11. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  12. Allen SD, et al. 2021. Biomaterials. 269:120635. PubMed
  13. Dube CT, et al. 2022. Epigenetics. 17:444. PubMed
  14. Xu J, et al. 2022. Dev Cell. 57:839. PubMed
  15. Hentzschel F, et al. 2022. Sci Adv. 8:eabm7348. PubMed
  16. Kalavska K, et al. 2022. Life (Basel). 12:. PubMed
  17. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  18. Jowett GM, et al. 2022. Cell Rep. 40:111281. PubMed
  19. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  20. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  21. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  22. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  23. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  24. Chen R, et al. 2023. Acta Pharm Sin B. 13:128. PubMed
  25. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  26. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  27. Vaillancourt M, et al. 2023. PLoS Pathog. 19:e1010942. PubMed
  28. Solier S, et al. 2023. Nature. 617:386. PubMed
  29. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  30. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  31. Pitzer Mutchler A, et al. 2023. Front Physiol. 14:1167904. PubMed
  32. Distel JS, et al. 2023. PLoS Pathog. 19:e1011173. PubMed
  33. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  34. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  35. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  36. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  37. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  38. Gawish R, et al. 2022. Elife. 11:. PubMed
  39. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  40. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  41. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  42. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  43. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  44. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  45. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  46. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  47. Poli V, et al. 2021. iScience. 24:103256. PubMed
  48. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  49. Alam J, et al. 2022. Mucosal Immunol. 15:620. PubMed
  50. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  51. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  52. Dong L, et al. 2021. Cancer Cell. . PubMed
  53. Pan XX, et al. 2021. Front Cell Dev Biol. 637424:9. PubMed
  54. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  55. Wang L, et al. 2022. Cancer Res Commun. 2:518. PubMed
  56. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  57. Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
  58. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  59. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  60. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  61. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  62. Wang Y, et al. 2021. Cancer Cell. 39:1375. PubMed
  63. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  64. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  65. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  66. Thanabalasuriar A et al. 2019. Cell Host Microbe. 25(4):526-536 . PubMed
  67. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  68. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  69. Xu Y, et al. 2021. Stem Cell Res Ther. 12:112. PubMed
  70. Yoshihara E, et al. 2020. Nature. 606:586. PubMed
  71. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  72. LaMarche NM, et al. 2020. Cell Metabolism. 32(2):243-258.e6. PubMed
  73. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  74. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  75. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  76. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  77. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  78. Wang H, et al. 2021. Malar J. 20:249. PubMed
  79. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  80. Taguchi K, et al. 2015. J Urol. . PubMed
  81. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  82. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  83. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  84. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  85. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  86. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  87. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  88. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  89. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  90. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  91. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  92. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  93. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  94. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  95. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  96. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  97. Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
  98. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  99. Jacobson A et al. 2018. Cell host & microbe. 24(2):296-307 . PubMed
  100. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  101. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  102. Kalavska K, et al. 2021. Int J Mol Sci. 22:. PubMed
  103. Lima-Junior DS, et al. 2021. Cell. . PubMed
  104. Alam J, et al. 2021. Front Immunol. 12:701415. PubMed
  105. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  106. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  107. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  108. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  109. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  110. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  111. Xiao Y, et al. 2018. Int Immunol. 30:457. PubMed
  112. Dang MT, et al. 2021. STAR Protoc. 2:100957. PubMed
  113. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  114. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  115. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  116. Ayari A, et al. 2020. Commun Biol. 3:237. PubMed
  117. Kalavska K, et al. 2022. Front Oncol. 12:858797. PubMed
  118. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  119. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  120. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  121. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  122. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
  123. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  124. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  125. Seki N, et al. 2022. iScience. 25:104838. PubMed
  126. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  127. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  128. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  129. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  130. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  131. Silva DA, et al. 2019. Nature. 565:186. PubMed
  132. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  133. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  134. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  135. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  136. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  137. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  138. Domanska D, et al. 2022. J Exp Med. 219:. PubMed
  139. Liu J, et al. 2022. Nat Commun. 13:4308. PubMed
  140. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  141. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  142. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  143. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  144. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  145. Smith LK, et al. 2021. Elife. 10:. PubMed
  146. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  147. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  148. Xia L, et al. 2021. Cell Chemical Biology. 28(5):610-624.e5. PubMed
  149. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  150. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  151. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  152. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  153. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  154. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  155. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  156. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  157. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  158. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  159. Weinstock A, et al. 2019. Immunometabolism. 1. PubMed
  160. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  161. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  162. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
  163. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  164. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  165. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  166. Yang Z, et al. 2022. Cancer Discov. 12:1942. PubMed
  167. Garnier L, et al. 2022. Sci Adv. 8:eabl5162. PubMed
  168. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  169. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  170. Caslin HL, et al. 2023. Front Immunol. 13:984859. PubMed
  171. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  172. Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed
  173. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  174. Allen SD, et al. 2021. Biomaterials. 269:120635. PubMed
  175. Dube CT, et al. 2022. Epigenetics. 17:444. PubMed
  176. Xu J, et al. 2022. Dev Cell. 57:839. PubMed
  177. Hentzschel F, et al. 2022. Sci Adv. 8:eabm7348. PubMed
  178. Kalavska K, et al. 2022. Life (Basel). 12:. PubMed
  179. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  180. Jowett GM, et al. 2022. Cell Rep. 40:111281. PubMed
  181. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  182. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  183. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  184. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  185. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  186. Chen R, et al. 2023. Acta Pharm Sin B. 13:128. PubMed
  187. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  188. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  189. Vaillancourt M, et al. 2023. PLoS Pathog. 19:e1010942. PubMed
  190. Solier S, et al. 2023. Nature. 617:386. PubMed
  191. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  192. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  193. Pitzer Mutchler A, et al. 2023. Front Physiol. 14:1167904. PubMed
  194. Distel JS, et al. 2023. PLoS Pathog. 19:e1011173. PubMed
  195. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  196. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  197. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  198. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  199. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  200. Gawish R, et al. 2022. Elife. 11:. PubMed
  201. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  202. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  203. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  204. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  205. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  206. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  207. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  208. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  209. Poli V, et al. 2021. iScience. 24:103256. PubMed
  210. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  211. Alam J, et al. 2022. Mucosal Immunol. 15:620. PubMed
  212. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  213. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  214. Dong L, et al. 2021. Cancer Cell. . PubMed
  215. Pan XX, et al. 2021. Front Cell Dev Biol. 637424:9. PubMed
  216. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  217. Wang L, et al. 2022. Cancer Res Commun. 2:518. PubMed
  218. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  219. Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
  220. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  221. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  222. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  223. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  224. Wang Y, et al. 2021. Cancer Cell. 39:1375. PubMed
  225. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  226. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  227. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  228. Thanabalasuriar A et al. 2019. Cell Host Microbe. 25(4):526-536 . PubMed
  229. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  230. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  231. Xu Y, et al. 2021. Stem Cell Res Ther. 12:112. PubMed
  232. Yoshihara E, et al. 2020. Nature. 606:586. PubMed
  233. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  234. LaMarche NM, et al. 2020. Cell Metabolism. 32(2):243-258.e6. PubMed
  235. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  236. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  237. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  238. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  239. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  240. Wang H, et al. 2021. Malar J. 20:249. PubMed
  241. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  242. Taguchi K, et al. 2015. J Urol. . PubMed
  243. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  244. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  245. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  246. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  247. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  248. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  249. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  250. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  251. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  252. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  253. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  254. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  255. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  256. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  257. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  258. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  259. Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
  260. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  261. Jacobson A et al. 2018. Cell host & microbe. 24(2):296-307 . PubMed
  262. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  263. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  264. Kalavska K, et al. 2021. Int J Mol Sci. 22:. PubMed
  265. Lima-Junior DS, et al. 2021. Cell. . PubMed
  266. Alam J, et al. 2021. Front Immunol. 12:701415. PubMed
  267. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  268. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  269. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  270. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  271. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  272. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  273. Xiao Y, et al. 2018. Int Immunol. 30:457. PubMed
  274. Dang MT, et al. 2021. STAR Protoc. 2:100957. PubMed
  275. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  276. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  277. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  278. Ayari A, et al. 2020. Commun Biol. 3:237. PubMed
  279. Kalavska K, et al. 2022. Front Oncol. 12:858797. PubMed
  280. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  281. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  282. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  283. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  284. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
  285. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  286. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  287. Seki N, et al. 2022. iScience. 25:104838. PubMed
  288. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  289. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  290. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  291. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  292. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  293. Silva DA, et al. 2019. Nature. 565:186. PubMed
  294. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  295. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  296. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  297. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  298. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  299. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  300. Domanska D, et al. 2022. J Exp Med. 219:. PubMed
  301. Liu J, et al. 2022. Nat Commun. 13:4308. PubMed
  302. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  303. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  304. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  305. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  306. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  307. Smith LK, et al. 2021. Elife. 10:. PubMed
  308. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  309. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  310. Xia L, et al. 2021. Cell Chemical Biology. 28(5):610-624.e5. PubMed
  311. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  312. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  313. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  314. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  315. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  316. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  317. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  318. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  319. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  320. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  321. Weinstock A, et al. 2019. Immunometabolism. 1. PubMed
  322. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  323. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  324. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
RRID
AB_2561392 (BioLegend Cat. No. 103137)
AB_2563061 (BioLegend Cat. No. 103138)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30F11_BV510_CD45_Antibody_FC_083112
C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
  • 30F11_BV510_CD45_Antibody_FC_083112
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
Compare all formats See Brilliant Violet 510™ spectral data
Cat # Size Price Quantity Check Availability Save
103137 125 µL NOK1502
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103138 50 µg NOK1997
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. For immunofluorescent staining using the µl size, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  2. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  3. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  4. Yang Z, et al. 2022. Cancer Discov. 12:1942. PubMed
  5. Garnier L, et al. 2022. Sci Adv. 8:eabl5162. PubMed
  6. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  7. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  8. Caslin HL, et al. 2023. Front Immunol. 13:984859. PubMed
  9. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  10. Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed
  11. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  12. Allen SD, et al. 2021. Biomaterials. 269:120635. PubMed
  13. Dube CT, et al. 2022. Epigenetics. 17:444. PubMed
  14. Xu J, et al. 2022. Dev Cell. 57:839. PubMed
  15. Hentzschel F, et al. 2022. Sci Adv. 8:eabm7348. PubMed
  16. Kalavska K, et al. 2022. Life (Basel). 12:. PubMed
  17. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  18. Jowett GM, et al. 2022. Cell Rep. 40:111281. PubMed
  19. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  20. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  21. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  22. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  23. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  24. Chen R, et al. 2023. Acta Pharm Sin B. 13:128. PubMed
  25. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  26. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  27. Vaillancourt M, et al. 2023. PLoS Pathog. 19:e1010942. PubMed
  28. Solier S, et al. 2023. Nature. 617:386. PubMed
  29. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  30. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  31. Pitzer Mutchler A, et al. 2023. Front Physiol. 14:1167904. PubMed
  32. Distel JS, et al. 2023. PLoS Pathog. 19:e1011173. PubMed
  33. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  34. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  35. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  36. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  37. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  38. Gawish R, et al. 2022. Elife. 11:. PubMed
  39. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  40. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  41. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  42. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  43. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  44. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  45. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  46. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  47. Poli V, et al. 2021. iScience. 24:103256. PubMed
  48. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  49. Alam J, et al. 2022. Mucosal Immunol. 15:620. PubMed
  50. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  51. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  52. Dong L, et al. 2021. Cancer Cell. . PubMed
  53. Pan XX, et al. 2021. Front Cell Dev Biol. 637424:9. PubMed
  54. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  55. Wang L, et al. 2022. Cancer Res Commun. 2:518. PubMed
  56. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  57. Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
  58. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  59. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  60. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  61. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  62. Wang Y, et al. 2021. Cancer Cell. 39:1375. PubMed
  63. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  64. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  65. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  66. Thanabalasuriar A et al. 2019. Cell Host Microbe. 25(4):526-536 . PubMed
  67. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  68. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  69. Xu Y, et al. 2021. Stem Cell Res Ther. 12:112. PubMed
  70. Yoshihara E, et al. 2020. Nature. 606:586. PubMed
  71. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  72. LaMarche NM, et al. 2020. Cell Metabolism. 32(2):243-258.e6. PubMed
  73. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  74. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  75. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  76. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  77. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  78. Wang H, et al. 2021. Malar J. 20:249. PubMed
  79. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  80. Taguchi K, et al. 2015. J Urol. . PubMed
  81. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  82. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  83. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  84. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  85. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  86. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  87. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  88. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  89. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  90. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  91. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  92. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  93. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  94. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  95. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  96. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  97. Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
  98. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  99. Jacobson A et al. 2018. Cell host & microbe. 24(2):296-307 . PubMed
  100. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  101. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  102. Kalavska K, et al. 2021. Int J Mol Sci. 22:. PubMed
  103. Lima-Junior DS, et al. 2021. Cell. . PubMed
  104. Alam J, et al. 2021. Front Immunol. 12:701415. PubMed
  105. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  106. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  107. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  108. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  109. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  110. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  111. Xiao Y, et al. 2018. Int Immunol. 30:457. PubMed
  112. Dang MT, et al. 2021. STAR Protoc. 2:100957. PubMed
  113. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  114. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  115. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  116. Ayari A, et al. 2020. Commun Biol. 3:237. PubMed
  117. Kalavska K, et al. 2022. Front Oncol. 12:858797. PubMed
  118. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  119. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  120. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  121. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  122. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
  123. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  124. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  125. Seki N, et al. 2022. iScience. 25:104838. PubMed
  126. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  127. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  128. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  129. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  130. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  131. Silva DA, et al. 2019. Nature. 565:186. PubMed
  132. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  133. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  134. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  135. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  136. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  137. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  138. Domanska D, et al. 2022. J Exp Med. 219:. PubMed
  139. Liu J, et al. 2022. Nat Commun. 13:4308. PubMed
  140. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  141. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  142. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  143. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  144. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  145. Smith LK, et al. 2021. Elife. 10:. PubMed
  146. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  147. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  148. Xia L, et al. 2021. Cell Chemical Biology. 28(5):610-624.e5. PubMed
  149. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  150. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  151. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  152. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  153. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  154. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  155. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  156. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  157. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  158. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  159. Weinstock A, et al. 2019. Immunometabolism. 1. PubMed
  160. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  161. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  162. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
  163. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  164. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  165. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  166. Yang Z, et al. 2022. Cancer Discov. 12:1942. PubMed
  167. Garnier L, et al. 2022. Sci Adv. 8:eabl5162. PubMed
  168. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  169. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  170. Caslin HL, et al. 2023. Front Immunol. 13:984859. PubMed
  171. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  172. Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed
  173. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  174. Allen SD, et al. 2021. Biomaterials. 269:120635. PubMed
  175. Dube CT, et al. 2022. Epigenetics. 17:444. PubMed
  176. Xu J, et al. 2022. Dev Cell. 57:839. PubMed
  177. Hentzschel F, et al. 2022. Sci Adv. 8:eabm7348. PubMed
  178. Kalavska K, et al. 2022. Life (Basel). 12:. PubMed
  179. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  180. Jowett GM, et al. 2022. Cell Rep. 40:111281. PubMed
  181. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  182. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  183. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  184. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  185. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  186. Chen R, et al. 2023. Acta Pharm Sin B. 13:128. PubMed
  187. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  188. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  189. Vaillancourt M, et al. 2023. PLoS Pathog. 19:e1010942. PubMed
  190. Solier S, et al. 2023. Nature. 617:386. PubMed
  191. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  192. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  193. Pitzer Mutchler A, et al. 2023. Front Physiol. 14:1167904. PubMed
  194. Distel JS, et al. 2023. PLoS Pathog. 19:e1011173. PubMed
  195. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  196. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  197. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  198. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  199. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  200. Gawish R, et al. 2022. Elife. 11:. PubMed
  201. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  202. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  203. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  204. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  205. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  206. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  207. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  208. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  209. Poli V, et al. 2021. iScience. 24:103256. PubMed
  210. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  211. Alam J, et al. 2022. Mucosal Immunol. 15:620. PubMed
  212. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  213. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  214. Dong L, et al. 2021. Cancer Cell. . PubMed
  215. Pan XX, et al. 2021. Front Cell Dev Biol. 637424:9. PubMed
  216. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  217. Wang L, et al. 2022. Cancer Res Commun. 2:518. PubMed
  218. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  219. Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
  220. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  221. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  222. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  223. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  224. Wang Y, et al. 2021. Cancer Cell. 39:1375. PubMed
  225. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  226. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  227. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  228. Thanabalasuriar A et al. 2019. Cell Host Microbe. 25(4):526-536 . PubMed
  229. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  230. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  231. Xu Y, et al. 2021. Stem Cell Res Ther. 12:112. PubMed
  232. Yoshihara E, et al. 2020. Nature. 606:586. PubMed
  233. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  234. LaMarche NM, et al. 2020. Cell Metabolism. 32(2):243-258.e6. PubMed
  235. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  236. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  237. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  238. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  239. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  240. Wang H, et al. 2021. Malar J. 20:249. PubMed
  241. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  242. Taguchi K, et al. 2015. J Urol. . PubMed
  243. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  244. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  245. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  246. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  247. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  248. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  249. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  250. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  251. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  252. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  253. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  254. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  255. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  256. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  257. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  258. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  259. Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
  260. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  261. Jacobson A et al. 2018. Cell host & microbe. 24(2):296-307 . PubMed
  262. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  263. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  264. Kalavska K, et al. 2021. Int J Mol Sci. 22:. PubMed
  265. Lima-Junior DS, et al. 2021. Cell. . PubMed
  266. Alam J, et al. 2021. Front Immunol. 12:701415. PubMed
  267. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  268. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  269. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  270. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  271. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  272. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  273. Xiao Y, et al. 2018. Int Immunol. 30:457. PubMed
  274. Dang MT, et al. 2021. STAR Protoc. 2:100957. PubMed
  275. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  276. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  277. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  278. Ayari A, et al. 2020. Commun Biol. 3:237. PubMed
  279. Kalavska K, et al. 2022. Front Oncol. 12:858797. PubMed
  280. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  281. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  282. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  283. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  284. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
  285. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  286. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  287. Seki N, et al. 2022. iScience. 25:104838. PubMed
  288. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  289. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  290. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  291. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  292. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  293. Silva DA, et al. 2019. Nature. 565:186. PubMed
  294. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  295. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  296. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  297. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  298. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  299. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  300. Domanska D, et al. 2022. J Exp Med. 219:. PubMed
  301. Liu J, et al. 2022. Nat Commun. 13:4308. PubMed
  302. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  303. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  304. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  305. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  306. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  307. Smith LK, et al. 2021. Elife. 10:. PubMed
  308. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  309. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  310. Xia L, et al. 2021. Cell Chemical Biology. 28(5):610-624.e5. PubMed
  311. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  312. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  313. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  314. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  315. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  316. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  317. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  318. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  319. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  320. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  321. Weinstock A, et al. 2019. Immunometabolism. 1. PubMed
  322. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  323. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  324. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
RRID
AB_2561392 (BioLegend Cat. No. 103137)
AB_2563061 (BioLegend Cat. No. 103138)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account